Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 2581 AL 2595

[Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease]

Blennow K, Hansson O.

Lakartidningen. 2024 May 31;121:23150.

Association of Loneliness with Functional Connectivity MRI, Amyloid-β PET, and Tau PET Neuroimaging Markers of Vulnerability for Alzheimer's Disease

Zhao A, Balcer LJ, Himali JJ, O'Donnell A, Rahimpour Y, DeCarli C, Gonzales MM, Aparicio HJ, Ramos-Cejudo J, Kenney R, Beiser A, Seshadri S, Salinas J.

J Alzheimers Dis. 2024;99(4):1473-1484. doi: 10.3233/JAD-231425.

Proteomics profiling of extracellular vesicle for identification of potential biomarkers in Alzheimer's disease: A comprehensive review

Pei J, Palanisamy CP, Jayaraman S, Natarajan PM, Umapathy VR, Roy JR, Thalamati D, Ahalliya RM, Kanniappan GV, Mironescu M.

Ageing Res Rev. 2024 Aug;99:102359. doi: 10.1016/j.arr.2024.102359. Epub 2024 May 29.

The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer's disease

Sarazin M, Lagarde J, El Haddad I, de Souza LC, Bellier B, Potier MC, Bottlaender M, Dorothée G.

Nat Aging. 2024 Jun;4(6):761-770. doi: 10.1038/s43587-024-00630-2. Epub 2024 Jun 5.

Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer's Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy

Sheng L, Bhalla R.

Neurochem Res. 2024 Sep;49(9):2273-2302. doi: 10.1007/s11064-024-04178-w. Epub 2024 Jun 6.

Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11β-HSD1 Inhibitor Xanamem® for Mild Alzheimer's Disease

Taylor J, Jaros M, Chen C, Harrison J, Hilt D.

J Alzheimers Dis. 2024;100(1):139-150. doi: 10.3233/JAD-231456.

Employing Informatics Strategies in Alzheimer's Disease Research: A Review from Genetics, Multiomics, and Biomarkers to Clinical Outcomes

Bao J, Lee BN, Wen J, Kim M, Mu S, Yang S, Davatzikos C, Long Q, Ritchie MD, Shen L.

Annu Rev Biomed Data Sci. 2024 Aug;7(1):391-418. doi: 10.1146/annurev-biodatasci-102423-121021. Epub 2024 Jul 24.

Alzheimer disease blood biomarkers: considerations for population-level use

Mielke MM, Fowler NR.

Nat Rev Neurol. 2024 Aug;20(8):495-504. doi: 10.1038/s41582-024-00989-1. Epub 2024 Jun 11.

TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer's disease

Vuoksimaa E, Saari TT, Aaltonen A, Aaltonen S, Herukka SK, Iso-Markku P, Kokkola T, Kyttälä A, Kärkkäinen S, Liedes H, Ollikainen M, Palviainen T, Ruotsalainen I, Toivola A, Urjansson M, Vasankari T, Vähä-Ypyä H, Forsberg MM, Hiltunen M, Jalanko A, Kälviäinen R, Kuopio T, Lähteenmäki J, Nyberg P, Männikkö M, Serpi R, Siltanen S, Palotie A, Kaprio J, Runz H, Julkunen V; FinnGen.

BMJ Open. 2024 Jun 12;14(6):e081947. doi: 10.1136/bmjopen-2023-081947.

Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease

Schindler SE, Galasko D, Pereira AC, Rabinovici GD, Salloway S, Suárez-Calvet M, Khachaturian AS, Mielke MM, Udeh-Momoh C, Weiss J, Batrla R, Bozeat S, Dwyer JR, Holzapfel D, Jones DR, Murray JF, Partrick KA, Scholler E, Vradenburg G, Young D, Algeciras-Schimnich A, Aubrecht J, Braunstein JB, Hendrix J, Hu YH, Mattke S, Monane M, Reilly D, Somers E, Teunissen CE, Shobin E, Vanderstichele H, Weiner MW, Wilson D, Hansson O.

Nat Rev Neurol. 2024 Jul;20(7):426-439. doi: 10.1038/s41582-024-00977-5. Epub 2024 Jun 12.

AI for the prediction of early stages of Alzheimer's disease from neuroimaging biomarkers - A narrative review of a growing field

Rudroff T, Rainio O, Klén R.

Neurol Sci. 2024 Nov;45(11):5117-5127. doi: 10.1007/s10072-024-07649-8. Epub 2024 Jun 13.

Neuroimaging for Early Diagnosis of Alzheimer's Disease: a Review

Ou CH, Liu TJ, Cheng CS, Lin PL, Lee CL.

Clin Lab. 2024 Jun 1;70(6). doi: 10.7754/Clin.Lab.2023.231141.

Identification and potential clinical applications of novel autophagy/mitophagy proteins in the biofluids of Alzheimer's disease patients

Zhang J, Wang HL, Veverová K, Vyhnálek M, Fang EF.

Ageing Res Rev. 2024 Aug;99:102378. doi: 10.1016/j.arr.2024.102378. Epub 2024 Jun 12.

Advances in blood biomarkers for Alzheimer disease (AD): A review

Assfaw AD, Schindler SE, Morris JC.

Kaohsiung J Med Sci. 2024 Aug;40(8):692-698. doi: 10.1002/kjm2.12870. Epub 2024 Jun 18.

Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study

Soleimani-Meigooni DN, Smith R, Provost K, Lesman-Segev OH, Allen IE, Chen MK, Cho H, Edwards L, Janelidze S, La Joie R, Mundada N, Ossenkoppele R, Stomrud E, Strandberg O, Strom A, Boxer AL, Dage JL, Gorno-Tempini ML, Kramer JH, Miller BL, Rojas JC, Rosen HJ, Lyoo CH, Hansson O, Rabinovici GD.

Ann Neurol. 2024 Sep;96(3):476-487. doi: 10.1002/ana.27008. Epub 2024 Jun 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias